The Questionnaire for Psychotic Experiences:An Examination of the Validity and Reliability by Rossell, Susan L. et al.
  
 University of Groningen
The Questionnaire for Psychotic Experiences
Rossell, Susan L.; Schutte, Maya J. L.; Toh, Wei Lin; Thomas, Neil; Strauss, Clara; Linszen,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Rossell, S. L., Schutte, M. J. L., Toh, W. L., Thomas, N., Strauss, C., Linszen, M. M. J., ... Sommer, I. E. C.
(2019). The Questionnaire for Psychotic Experiences: An Examination of the Validity and Reliability.
Schizophrenia Bulletin, 45(1), S78-S87. https://doi.org/10.1093/schbul/sby148
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 13-11-2019
S78
Schizophrenia Bulletin vol. 45 suppl. no. 1 pp. S78–S87, 2019 
doi:10.1093/schbul/sby148
© The Author(s) 2019. Published by Oxford University Press on behalf  of the Maryland Psychiatric Research Center.  
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial  
re-use, please contact journals.permissions@oup.com
INVITED THEME ARTICLE
The Questionnaire for Psychotic Experiences: An Examination of the Validity and 
Reliability
Susan L. Rossell*,1,2, Maya J. L. Schutte3,4, Wei Lin Toh1, Neil Thomas1, , Clara Strauss5, Mascha M. J. Linszen4,6, 
Edwin van Dellen4, Sophie M. Heringa4, Rob Teunisse7, Christina W. Slotema8, and Iris E. C. Sommer3,9
1Centre for Mental Health, Swinburne University of Technology, Hawthorn, Melbourne, Australia; 2Department of Psychiatry, St 
Vincent’s Hospital, Melbourne, Australia; 3Department of Neuroscience and Department of Psychiatry, University Medical Center 
Groningen, The Netherlands; 4Department of Psychiatry, University Medical Center Utrecht and Brain Center Rudolf Magnus, Utrecht, 
The Netherlands; 5School of Psychology, University of Sussex and Sussex Partnership NHS Foundation Trust, Sussex, UK; 6Alzheimer 
Center, Department of Neurology, Neuroscience Campus, VU University Medical Center, Amsterdam, The Netherlands; 7Department 
of Geriatric Psychiatry, Dimence, Deventer, The Netherlands; 8Department of Personality Disorders, Parnassia Psychiatric Institute, The 
Hague, The Netherlands; 9Department of Biological and Medical Psychology, University of Bergen, Bergen, Norway
*To whom correspondence should be addressed; Centre for Mental Health, Swinburne University of Technology, John St., Hawthorn, 
Melbourne, VIC 3122, Australia, tel: +61 3 9214 8173, fax: +61 3 9214 8173, e-mail: srossell@swin.edu.au
Psychotic experiences are prevalent across a wide variety of 
psychiatric, neurological, and medical conditions. Yet cur-
rent assessments are often designed for one disorder, or are 
limited in their examination of phenomenological features; 
this has hindered transdiagnostic research. This article 
describes an examination of the validity and reliability of 
the English version of a new assessment, the Questionnaire 
for Psychotic Experiences (QPE). This study aimed to use 
the QPE to examine hallucinations and delusions across a 
number of different conditions, and to ensure that the QPE 
had acceptable psychometric properties. An International 
Consortium on Hallucination Research working group, 
along with consumer groups, developed the 50-item QPE 
to assess the presence, severity, and phenomenology of hal-
lucinations and delusions. Participants in the study who 
reported psychotic experiences included those with schizo-
phrenia, schizoaffective disorder, bipolar affective disorder, 
and major depressive disorder, and those without a need for 
care (ie, nonclinical participants). There were 173 partici-
pants in total. Convergent and discriminant validity were 
assessed. Reliability was examined in terms of stability, 
equivalence, and internal consistency. The data confirmed 
that the QPE had good psychometric properties and could 
be put forward as an accepted measure of the transdiag-
nostic evaluation of psychotic experiences. Further vali-
dation is recommended with neurological and medical 
populations. Given its validity and reliability, comprehen-
sive evaluation of psychotic phenomena, and relatively 
quick administration time, we propose that the QPE is a 
valuable instrument for both clinical and research settings.
Key words:  Questionnaire for Psychotic Experiences 
(QPE)/scale validation/psychotic experiences/ 
transdiagnostic
Introduction
Psychotic experiences, such as hallucinations and delu-
sions, are common in psychiatric disorders, eg, schizo-
phrenia, bipolar disorder, and major depressive disorders. 
They also occur in a proportion of the general popula-
tion, as well as in neurological illnesses and medical 
conditions.1 There is a comprehensive literature that has 
presented the phenomenological characteristics of hallu-
cinations and delusions in schizophrenia,2 yet there is a 
considerable paucity of investigation across most other 
conditions in psychiatry, neurological disorders, as well 
as medical illnesses; see Burghaus et al,3 Merrett et al,4 
and Toh et al5 for reviews in the field.
The most commonly reported psychotic experiences 
are hallucinations in the auditory and visual modali-
ties, as well as delusions. Yet most instruments that are 
used to examine phenomenology tend to focus solely on 
one modality, typically auditory hallucinations (AHs; 
eg, Psychotic Symptom Rating Scales [PSYRATS6]), or 
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Thinking Scale7). A number of other instruments, such 
as the Positive and Negative Syndrome Scale (PANSS8), 
assess delusions and hallucinations, but do not indepen-
dently rate individual delusional themes or hallucination 
modalities with only global scores calculated. Further, 
there has been a paucity of study with regard to other 
psychotic phenomenon, eg, olfactory and somatic hallu-
cinations, as well as both auditory and visual illusions. 
Sensed presence(s) is another sensory domain that has 
been rarely investigated, with some limited evidence 
that such experiences are overrepresented in bereaved 
populations.9 In addition, existing measures were pri-
marily developed with singular or limited populations 
under consideration, with the majority of these instru-
ments suited to examine psychotic experiences in schizo-
phrenia spectrum disorders (ie, the PSYRATS), and a 
handful specifically designed for visual hallucinations 
(VHs) in neurodegenerative disorders (ie the Northeast 
Visual Hallucinations Interview [NEVHI]10). This limits 
a comprehensive understanding of psychotic experiences 
both within and across conditions. Therefore, to facili-
tate transdiagnostic comparisons of the broad range of 
psychotic phenomenon, a new measure was developed 
to assess psychotic experiences independent of diagno-
sis. The measure is called the Questionnaire for Psychotic 
Experiences (QPE; see www.qpeinterview.com/en), and 
it assesses the presence and phenomenology of auditory, 
visual, tactile, and olfactory hallucinations (OHs); sensed 
presence (SP), and concurrent multimodal hallucina-
tions; and 9 common types of delusions. The QPE was 
designed to be used within the context of an interview.
The current study represents the first published validation 
of the QPE, and aimed to determine whether the English 
version offers accurate, valid, and interpretable data, by 
examining its psychometric properties, ie, completion rates, 
validity, and reliability. Construct validity will be explored 
via convergent and discriminant validity. Reliability was 
examined in terms of stability, equivalence, and internal 
consistency. This was to ensure that the QPE was showing 
similar patterns in the phenomenology of psychotic experi-
ences to the considerable literature already published in the 
field in relation to schizophrenia spectrum disorders.
Methods
The Questionnaire for Psychotic Experiences
An International Consortium on Hallucination 
Research working group consisting of  a panel of  experts 
of  different backgrounds (psychology, psychiatry, neu-
rology) and consumer representatives developed the 
50-item QPE. The QPE assesses the presence, severity, 
and phenomenological characteristics of  hallucinations 
and delusions. The aim was to ensure that the QPE was 
transdiagnostic; therefore, existent instruments were 
screened for relevant items. These included PSYRATS,6 
NEVHI,10 Scale for the Assessment of  Positive 
Symptoms (SAPS11), Launay and Slade Hallucinations 
Scale12 and Cardiff  Anomalous Perceptions Scale13, the 
Schedule for Clinical Assessment in Neuropsychiatry14, 
Community Assessment of  Psychic Experiences,15 and 
Peters Delusional Inventory16. Fifty items were selected 
via our expert working group and via consumer consul-
tation in the Melbourne (NT) and Sussex (CS) Voices 
Clinics, and modified into a standard format. The 
items that examined hallucinations gathered thorough 
information on auditory, visual, olfactory, tactile, and 
multimodal hallucinations and SP(s). The items on delu-
sions covered the most frequent themes of  delusions: 
paranoid, reference, guilt, control, religious, grandeur, 
somatic, Cotard’s syndrome (the conviction that one 
was dead or that part of  the body has already died), and 
Capgras syndrome (the conviction that a known person 
has been replaced by an imposter). The latter 2 delu-
sions were included as they are more common in neu-
rological populations and are not typically employed in 
psychiatric assessments. The items were arranged into 
4 modules or subscales: AHs, VHs, hallucinations in 
other modalities, and delusions (D). The questionnaire 
was completed during a semi-structured interview. The 
majority of  items were initially explored using a ser-
ies of  predetermined questions; participants were sub-
sequently required to narrow down their answers to a 
forced-choice response with regard to severity (6-point 
numerical scale see Supplementary Material) or phe-
nomenological characteristics (alphabetical descrip-
tives across 5–7 possibilities depending on the item see 
Supplementary Material). In addition, <10% of  the 
items were open and required a short description of  the 
experience, which was written verbatim. The QPE takes 
between 20 and 40 min to complete depending on the 
number of  psychotic experiences a participant endorses. 
We assessed psychotic experiences across 2 time frames: 
(1) lifetime experiences (lifetime) and (2) experiences in 
the past 7 days (current). Thus, in this report there are 
two scores for each of  the 50 items: lifetime scores and 
current scores.
Overall, the QPE permits analyses across the 4 sub-
scales: AH, VH, total hallucinations (TotH), and D as well 
as giving a total severity of psychotic experiences, or total 
QPE score (thus 5 scores in total). For each of the sub-
scales, the severity forced-choice items were summed. This 
included the following items for AH and VH: frequency, 
duration, distress, and impact; and for D: conviction, pre-
occupation, distress, and impact (with each of the AH, 
VH, and D items having a 6-point numerical scale from 0 
to 5, the items relating to phenomenological characteris-
tics were not included in these subscale scores). TotH and 
total QPE also included frequency of tactile hallucinations 
(THs), frequency of OHs, frequency of multimodal hal-
lucinations, and frequency of SP (other severity informa-
tion, ie, distress and impact, for these latter 4 hallucination 













To examine convergent validity, a series of current “gold 
standard” measures in their class were included in the 
assessment to investigate whether the QPE was in accord-
ance with instruments that measured similar constructs. 
A semi-structured interview format was required for each 
of the measures selected as gold standard to ensure maxi-
mal compatibility. Self-report measures were not selected. 
Our measures included the PSYRATS,6 PANSS,8 SAPS,11 
and the NEVHI.10 The PSYRATS has two subscales rele-
vant to the current study: AH and delusions. The PANSS 
has two items from the positive scale that were relevant: 
an item score for delusions (P1) and an item score for hal-
lucinations (P3). The SAPS has two subscales relevant: 
hallucinations and delusions. The delusion subscale of 
the SAPS was used in the convergent validity analyses to 
correlate with the D of the QPE. As the SAPS halluci-
nation subscale sums across auditory and visual items, 
we used the individual SAPS item scores for auditory 
and VHs in the convergent validity analyses to corre-
late with the relevant subscales of the QPE. The NEHVI 
provides a total VH severity score, which was correlated 
with the VH subscale of the QPE. Psychotic and mood 
symptom severity were also obtained using the PANSS, 
Beck Depression Inventory (BDI-II17) and Beck Anxiety 
Inventory (BAI18). For the correlations performed dur-
ing the discriminant function analyses, the total scores 
of BDI and BAI were used, as well as the negative and 
general subscales of the PANSS, as the positive PANSS 
subscale assesses for hallucinations and delusions and 
was included in the convergent validity correlations. The 
measures chosen to investigate discriminant validity rep-
resent common symptoms experienced in psychosis, ie, 
negative symptoms, general symptoms, depression, and 
mood, but are not expressions of psychotic experiences. 
For both convergent and discriminant validity, only 4 
of the QPE subscales were used, AH, VH, D, and total 
QPE. When designing the battery, there were no other 
instruments available in the literature that assessed hal-
lucinations in other modalities, ie, THs, OHs, multimodal 
hallucinations, or SP in a semi-structure interview for-
mat (SAPS does have olfactory and tactile but not multi-
modal hallucinations or SP).
Participants
Participants were recruited across in- and outpatient 
services of The Alfred Hospital, St Vincent’s Hospital, 
and The Melbourne Clinic, as well as community sup-
port groups and forums (the latter was particularly 
important for recruiting the nonclinical participants), all 
in Melbourne, Australia. Inclusion criteria for all partici-
pants were that they needed to be ≥18 years of age, be 
fluent English language speakers, and have the capacity 
to adequately answer questions and communicate their 
thoughts (ie, an absence of gross thought disorder). With 
regard to hallucinations, participants must have experi-
enced AH at least 3 times over their lifetime to be included 
(this needed to be a significant or notable experience each 
time, ie, >2 min, and could not be a hearing of the name 
or very fleeting experience, ie, <20 s). If  these symptoms 
were experienced within the past 7 days, a designation of 
current AH was given. When participants were assessed 
on lifetime AH, they were asked to reflect upon their 
most prominent or “worst ever” episode. Four clinical 
group were recruited: schizophrenia, schizoaffective dis-
order, bipolar disorder, and major depressive disorder. 
An additional nonclinical group was also recruited; these 
included persons with a history of current or lifetime 
AHs without a need for care, ie, no diagnosis of a men-
tal health disorder. All participants completed the Mini 
International Neuropsychiatric Interview (MINI19) to 
confirm their primary Diagnostic and Statistical Manual 
of Mental Disorders - IV - Text Revision psychiatric 
diagnosis (the nonclinical group was verified as not hav-
ing any current psychiatric diagnosis on the MINI). Basic 
demographic characteristics were obtained for the sample 
including age, gender, and education (see table 1).
Procedure
All measures were administered in the same order, in 
accordance with the specific instructions outlined for 
each individual measure. All raters (W.L.T., M.S., M.R., 
S.L.R.: psychologists or trained higher degree students) 
were trained to administer the assessment. To enable us 
to examine test–retest reliability, a random 10% (N = 16) 
of the total sample were assessed again 1–14  days 
after the original assessment (range 1–14  days, mean 
5.8 [SD  =  4.4]). Session 1 included the full assessment 
described earlier, and session 2 repeated the QPE for the 
last 7 days only. The same 10% subsample was also used 
to calculate inter-rater reliability, with two raters assess-
ing the same participant on session 2. The study was per-
formed in accordance with the Declaration of Helsinki20 
and received ethical approval from the Alfred Hospital 
Human Research Ethics Committee (HREC 341/14), 
Melbourne, Australia. Each participant provided written 
informed consent prior to assessment.
Statistical Analyses
Acceptability. Data quality was considered acceptable if  
more than 95% of participants completed the interview.
Validity. Six principal component analyses (PCA) were 
performed to complete a cross-validation of the factor 
structure of the QPE in line with preliminary analyses 
performed during the scale development phase (www.
qpeinterview.com/en): one PCA per subscale (AH, VH, 
and D) for each time frame (lifetime and current). For 
each subscale all items, 15 each for AH and VH and 5 
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forced-choice items for severity and phenomenological 
characteristics. During development, 3-factor models for 
the AH and VH subscales and a 1-factor solution for D 
were demonstrated. The current analyses sought to con-
firm these factor solutions. Promax rotations were used, 
given the ordinal nature of the items and expected cor-
relations between them. Eigen values greater than 1 and 
factor loadings of greater than 0.4 were retained and 
considered satisfactory (see Mokkink et  al21). To assess 
for convergent validity, inter-scale correlations were per-
formed between the QPE and diagnosis-specific instru-
ments measuring similar constructs; this included the 
PSYRATS, PANSS hallucination and delusion items, 
SAPS and NEVHI. To assess for discriminant validity, 
instruments that assessed general psychopathology and 
mood were used. These included PANSS negative and 
general, BDI and BAI. All inter-scale correlations were 
conducted using Kendall’s tau due to non-normality.
Reliability. For the stability and equivalence analyses, 
the 6 subscale scores for current experiences were calcu-
lated using the forced-choice severity items only. First, 
stability (how consistent or stable an assessment is over 
time) was examined using the test–retest intra-class cor-
relation coefficients (ICC; for all ICC analyses 2-way 
mixed, average measures, consistency models were used) 
for all 4 subscale scores and the total QPE across the 
2 sessions. When performing our stability analyses, an 
error was noted with regard to our strategy of  retest a 
maximum of 14 days later. The QPE interview requires 
participants to reflect upon the previous 7  days. Two 
of our participants were retested 13 and 14  days after 
their initial interview (all of  the other 14 participants 
were retested within a 7-day window). Their status for 
the VH subscale changed from present to absent across 
the 2 time periods; thus they were removed from the VH 
ICC analysis. Their data were included for all the other 
subscale scores and for the total QPE subscale score (just 
removing the visual subscale) as their presence status for 
other psychotic experiences remained the same over the 
2 assessment points (NB whether we removed all of  these 
2 participants data or just the visual subscales made no 
difference to the final results presented). Second, equiv-
alence was determined using ICC for inter-rater relia-
bility. Third, internal consistency of  each subscale was 
determined using Cronbach’s α coefficient. Inter-scale 
correlations between subscales of  the QPE were also cal-
culated. A Cronbach’s α between .70 and .95 is argued to 
reflect good internal consistency.22
Results
Participants
A total of 173 participants with schizophrenia (n = 50), 
schizoaffective disorder (n  =  26), bipolar disorder 
(n = 31), and major depressive disorder (n = 34) as well 










n 50 26 31 34 32
Age (M [SD]) 40.3 (11.1) 43.4 (10.7) 32.1 (12.8) 30.2 (12.8) 28.6 (8.9)
Sex (male:female) 22:28 8:18 16:15 14:20 15:17
Educationa(M [SD]) 13.8 (3.4) 13.7 (2.8) 15.6 (3.9) 14.1 (2.1) 15.5 (2.2)
WTAR IQ (M [SD]) 102.2 (12.8) 104.5 (11.4) 107.6 (11.5) 106.4 (9.4) 102.8 (8.6)
PANS P (M [SD]) 19.4 (5.9) 16.3 (5.7) 16.0 (5.3) 12.6 (3.7) 10.7 (2.9)
PANS N (M [SD]) 13.5 (5.5) 11.9 (4.8) 10.2 (3.4) 10.8 (3.7) 8.3 (1.4)
PANSS G (M [SD]) 34.1 (8.3) 34.2 (9.7) 30.8 (8.2) 30.5 (8.4) 22.3 (4.1)
PANSS T (M [SD]) 67.0 (15.9) 62.5 (16.2) 57.0 (14.9) 54.0 (14.3) 41.3 (6.5)
BDI (M [SD]) 17.0 (11.7) 20.7 (13.0) 21.2 (15.2) 21.4 (15.7) 6.6 (7.4)
BAI (M [SD]) 16.7 (12.0) 20.1 (12.2) 25.5 (17.9) 22.4 (13.3) 9.1 (8.2)
Medicationb None = 13.6% None = 8.0% None = 22.6% None = 55.9% None = 93.8%
AP = 47.7% AD = 4.0% AD = 16.1% AD = 23.5% AD = 6.2%
AP + AD = 22.7% AP = 16.0% MS = 6.5% AX = 5.9%
AP + MS = 6.8% AP + AD = 52.0% AP = 12.9% AP + AD = 5.8%
AP + AX = 9.1% AP + MS = 8.0% AP + AD = 19.4% AD + MS = 8.8%
AP + AX = 8.0% AP + MS = 16.1%
AD + AX = 4.0% AD + MS = 6.5%
Note: M, mean; SD, standard deviation; WTAR, Weschler Adult Reading Test (used to calculate premorbid IQ); PANS P, Positive 
and Negative Syndrome Scale Positive; PANS N, Positive and Negative Syndrome Scale Negative; PANNS G, Positive and Negative 
Syndrome Scale General; PANSS T, Positive and Negative Syndrome Scale Total; BDI, Beck Depression Inventory; BAI, Beck Anxiety 
Inventory; MS, mood stabilizer; AD, antidepressant; AP, antipsychotic; AX, anxiolytics.
aEducation calculated as the number of years in formal education (includes school and university education).
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as nonclinical participants (n = 32) were administered the 
QPE. Basic participant characteristics are presented in 
table 1.
Figure  1 shows the variety of psychotic experiences 
endorsed across the different groups. As per our recruit-
ment strategy, all participants (100%) had experienced AH 
in their lifetime, with AH currently experienced in 38%–
76% of the participant subgroups. The schizophrenia and 
schizoaffective groups had similar endorsement rates across 
all the other psychotic experiences, with a large majority 
also experiencing delusions (lifetime ~90%, current ~60%), 
and approximately 50% of both samples reporting halluci-
nations in other modalities. The two mood disorder groups 
showed similar rates of endorsement (both lifetime and cur-
rent) across all the psychotic experiences except delusions, 
which the bipolar group reported approximately twice as 
often, both for lifetime and current. The nonclinical group 
showed the lowest endorsement across the other psychotic 
experiences. All groups reported SP currently and across 
their lifetime (19%–45% of cases).
Acceptability
After consent was obtained, 100% of the sample reached 
the end of the QPE interview, illustrating high comple-
tion rates. One participant declined to answer any ques-
tions on the VH subscale but completed all other items. 
The average time to complete the interview was 30 min 
(range 20–60  min), depending on the number of psy-
chotic experiences and response speed.
Validity
A 3-factor solution was supported for the AH and VH 
subscales for both current and lifetime (table 2) data. For 
Fig. 1. Symptom profiles of all participants who endorsed psychotic experiences, lifetime (N = 173: 100%) and currently (N = 126: 
72.8%), display by diagnosis: (a) schizophrenia, (b) schizoaffective disorder, (c) bipolar affective disorder, (d) major depressive 
disorder, and (e) nonclinical controls. AH, auditory hallucination; VH, visual hallucination; TH, tactile hallucinations; OH, olfactory 









roningen user on 17 July 2019
S83
English QPE
the AH subscale, the analyses on the current experiences 
yielded the following dimensions: impact on functioning, 
incidence, and illusions. These factors accounted for 63% 
of the variance with a total fit of 0.99. For the lifetime 
AH subscale, a slightly different 3-factor solution was 
ascertained relating to impact on functioning, insight, and 
illusions. The solution accounted for 49% of the variance 
with 0.93 fit. Only one item “past experiences” failed to 
load on any of the 3 factors for both current and lifetime 
data. For the current VH subscale, the same dimensions 
as for AH subscale were found: impact on functioning, 
incidence, and illusions. These factors accounted for 76% 
of the variance with a total fit of 0.97. For the lifetime 
VH subscale, a slightly different 3-factor solution was 
ascertained to lifetime AH but the same as current AH 
relating to incidence, impact on functioning, and illusions. 
The solution accounted for 65% of the variance with 0.99 
fit. All items loaded on at least one of the factors for both 
current and lifetime data. A unidimensional model was 
present for delusions (with all items loading on this fac-
tor), labeled impact on functioning. For the current data, 
the solution accounted for 73% of the variance with a 
0.97 fit and for the lifetime data, 80% of the variance with 
0.9 fit.
For convergent validity (all instruments expected to 
measure a similar construct as the QPE), we performed 
84 correlations in n = 173 participants, with 19 predicted 
to show a significant correlation at P < .0001 (this P 
value is conservatively corrected for multiple compari-
sons using Bonferroni23), with r > .55 at this P-value. All, 
but one, of the 19 predicted correlations were significant, 
and the remaining 65 correlations were not significant. 
The data are displayed in table 3. In sum, QPE total AH 
subscale correlated with PSYRATS AH but not with the 
delusion subscale of the PSYRATS. Similarly the QPE 
D subscale correlated with the delusion score of the 
PSYRATS, but not the AH subscale. The PANSS hallu-
cination item was correlated with QPE AH, but not VH, 
Table 2. Principal Component Analysis With Promax Rotations Carried Out Within Three of the QPE Subscales
Auditory Hallucinations Visual Hallucinations Delusions
No Item 1 2 3 No Item 1 2 3 No Item 1
Current Experiences
AH6 Impact 0.86 VH13 Commands 0.92 D10 Preoccupation 0.93
AH5 Distress 0.84 VH4 Emotional 0.87 D11 Conviction 0.88
AH13 Commands 0.82 VH3 Duration 0.87 D12 Distress 0.88
AH12 Interaction 0.79 VH11 Insight 0.84 D13 Impact 0.85
AH8 Complexity 0.75 0.62 VH12 Interaction 0.84 D14 Impact 
hallucinations
0.71
AH4 Emotional 0.69 VH2 Past event 0.73
AH11 Insight 0.61 VH9 Location 0.95
AH7 Repetition 0.93 VH8 Complexity 0.92
AH10 Time day 0.86 VH7 Repetition 0.89
AH9 Location 0.80 VH10 Time day 0.88
AH1 Frequency 0.79 VH1 Frequency 0.86 0.33
AH3 Duration 0.50 0.63 0.33 VH15 Illusions 0.85
AH14 Music 0.75 VH14 Passage 0.84
AH15 Illusions 0.59 VH5 Distress 0.54 0.82
A2 Past event 0.00 VH6 Impact 0.55 0.70
Lifetime Experiences
AH6 Impact 0.88 VH2 Past event 0.88 D10 Preoccupation 0.93
AH3 Duration 0.83 VH8 Complexity 0.88 D12 Distress 0.92
AH1 Frequency 0.81 VH13 Commands 0.86 D13 Impact 0.91
AH5 Distress 0.79 VH7 Repetition 0.83 D11 Conviction 0.91
AH4 Emotional 0.75 VH9 Location 0.79 D14 Impact 
hallucinations
0.81
AH13 Commands 0.65 VH3 Duration 0.75
AH8 Complexity 0.57 VH11 Insight 0.74
AH7 Repetition 0.50 VH10 Time day 0.71
AH12 Interaction 0.39 0.48 VH12 Interaction 0.62
AH10 Time day 0.65 VH6 Impact 0.87
AH11 Insight 0.60 VH5 Distress 0.87
AH9 Location 0.51 VH4 Emotional 0.61 0.74
AH14 Music 0.76 VH15 Illusions 0.82
AH15 Illusions 0.64 VH14 Passage 0.67
AH2 Past event 0.40 VH1 Frequency 0.38 0.66
Note: All loadings were >0.4; where loadings did not meet this threshold, they have been included but shaded in light gray. A total of 
N = 173 participants who reported auditory hallucinations either currently or lifetime were included. No, item number; AH, auditory 
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with PANSS scores only rated currently and not for life-
time in this study. This result illustrates that the PANSS 
hallucination item does not adequately assess VH. The 
PANSS delusions item was correlated with QPE D. The 
SAPS AH and VH items as well as the delusion subscales 
significantly correlated with the equivalent subscales on 
the QPE. Finally, the NEVHI correlated with the QPE 
VH subscale and nothing else. For discriminant validity 
(all instruments expected to measure a different construct 
as compared to the QPE), we performed 32 correlations 
with none expected to show a significant correlation at P 
< .0001 with r > .55. This data are displayed in table 3 and 
was as predicted.
Reliability
Reliability data are presented in table  4, representing 
stability and equivalence. The ICC for stability ranged 
between 0.70 and 0.92, and for equivalence 0.99 and 
1.00. Table 4 also displays the internal consistency. The 
QPE subscales showed good internal consistency with 
Cronbach’s α ranging from .75 to .90 for lifetime experi-
ences, and 0.70 to 0.89 for current experiences. The inter-
scale correlations were low and nonsignificant across the 
subscales (ie, AH, VH, and D), with the exception of AH 
with D, which was significant. Individual subscales were 
correlated with total subscale scores (ie, AH with TotH 
and QPE). Overall, this indicates that the different sub-
scales measured different types of psychotic experiences.
Discussion
The current study aimed to report the psychometric 
properties, ie, the validity and reliability, of the English 
version of the QPE. We recruited and administered the 
instrument to a large cohort of participants, including 
those with schizophrenia spectrum disorders, affective 
psychoses, and nonclinical participants. The completion 
rates were extremely high, ie, 100%, illustrating that the 
items were accepted by participants, and they were easily 
able to provide responses within the numerical and alpha-
betic forced-choice outlined for each item. In most cases, 
the interviews were brief, approximately 30 min; longer 
interviews were only needed when multiple experiences 
were present or patients were acutely unwell, necessitat-
ing longer response times.
The QPE gathered data on a wide range of psychotic 
experiences present in our cohort. Auditory hallucina-
tions were the most frequent phenomenon reported 





AH VH D QPE
L C L C L C L C
Convergent Validity Inter-scale Correlations
PSYRATS AH L 0.84*** 0.36 0.44 0.18 0.56*** 0.27
C 0.31 0.86*** 0.22 0.35 0.29 0.67***
D L 0.48 0.21 0.93*** 0.35 0.59*** 0.30
C 0.18 0.36 0.34 0.95*** 0.25 0.60***
PANSS H C 0.47 0.58*** 0.06 0.11 0.26 0.44
D C 0.44 0.37 0.10 0.07 0.48 0.73***
SAPS AH L 0.69*** 0.29 0.10 0.04 0.46 0.26
C 0.44 0.61*** 0.05 0.17 0.23 0.36
VH L 0.11 0.08 0.68*** 0.41 0.12 0.09
C 0.13 0.23 0.37 0.66*** 0.07 0.21
D L 0.53 0.23 0.15 0.09 0.72*** 0.44
C 0.33 0.41 0.09 0.16 0.36 0.75***
NEVHI VH L 0.09 0.06 0.63*** 0.41 0.09 0.05
C 0.07 0.21 0.39 0.65*** 0.07 0.14
Discriminant Validity Inter-scale Correlations
PANSS Neg. 0.22 0.29 0.03 0.04 0.24 0.37 0.16 0.29
Gen. 0.29 0.42 0.01 0.16 0.27 0.53 0.23 0.47
BDI 0.19 0.25 0.13 0.17 0.14 0.23 0.21 0.29
BAI 0.18 0.27 0.06 0.13 0.14 0.18 0.17 0.28
Note: Shaded boxes predicted significant correlations. AH, auditory hallucination; VH, visual hallucination; D, delusions; QPE, total 
severity psychotic experiences on the Questionnaire for Psychotic Experiences; PSYRATS, Psychotic Symptom Rating Scales; SAPS, 
Scale for the Assessment of Positive Symptoms; NEVHI, Northeast Visual Hallucinations Interview; PANSS, Positive and Negative 
Syndrome Scale; H, Hallucinations; Neg., negative subscale; Gen, general subscale; BDI, Beck Depression Inventory; BAI, Beck Anxiety 
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the groups (schizophrenia, schizoaffective disorder, and 
bipolar disorder), a finding that is supported by the lit-
erature for these diagnostic conditions.24 Inclusion of a 
nonclinical group was useful as it established that the 
QPE can detect psychotic experiences in participants that 
do not have frequent contact with health professionals 
and have perhaps not over medicalized their experiences. 
Further, there was significant endorsement of tactile and 
olfactory hallucinations as well as SP in all of the cohorts; 
these experiences are not typically captured on current 
assessments, thus confirming the need for the QPE.
Our analyses established that the psychometric prop-
erties of the QPE are excellent. The PCA confirmed a 
3-factor solution for both auditory and VHs, and a uni-
dimensional solution for delusions. All but one of our 
items showed a high loading onto a single factor and was 
thus not redundant. Of note, the underlying dimensions 
of each subscale represented sensible phenomenological 
categories within hallucinations research. For both audi-
tory and visual hallucinations, factors of incidence, illu-
sions, and impact on functioning were evident, with insight 
emerging as a factor for lifetime AH but not VH. Indeed, 
previous research has noted similar physical, cognitive, 
emotional, and impact on functioning dimensions.2
Our convergent validity predictions were 96% accurate. 
The QPE was significantly correlated with the current 
most widely used measures in the field on the appropri-
ate corresponding items or subscales. This was true for 
psychotic experiences reported currently and over the 
lifetime. None of the correlations outside our predictions 
were significant. Further, the data demonstrated that 
there were no significant correlations between the QPE 
subscales and general psychopathology or mood meas-
ures. Both these results confirmed that the QPE has spec-
ificity, and is measuring psychotic experiences, and not 
general features of mental illness.
Our reliability was excellent, with 100% accuracy for 
inter-rater assessments and 70%–92% accurate for test–
retest. Such high rates of equivalence speak to accurate 
wording of the items as well as clearly defined forced-
choice responses, allowing participants to easily select 
their category of response. Both raters were subsequently 
easily able to detect the response selected. Stability of the 
results may be more conservative, as they assume that a 
person’s response remains the same over time. However, 
psychotic experiences are known to be remarkably unsta-
ble over the course of a persons’ illness, and wax and 
wane over acute and chronic periods. The current data 
indeed illustrate this, with 2 patients showing different 
presentations of VH over the 2 sessions due to a slightly 
longer gap between sessions (thus excluding them from 
the analyses). Overall, the current data do suggest that 
when tested within a short <7  day time window, there 
is stability of responses on the QPE. Finally, there was 














Internal Consistencyb and Inter-subscale Correlations
AH VH TotH D QPE
AH L 0.78
C 0.70
VH L 0.07 L 0.86
C 0.29 C 0.75
TotH L 0.48** L 0.60** L 0.75
C 0.75** C 0.55** C 0.76
D L 0.51** L 0.10 L 0.58** L 0.90
C 0.39** C 0.14 C 0.55** C 0.89
QPE L 0.55** L 0.47** L 0.79** L 0.58** L 0.85
C 0.71** C 0.46** C 0.82** C 0.55** C 0.86
Note: AH, auditory hallucination total score; VH, visual hallucination total score; TotH, total hallucinations; D, delusions; QPE, total 
severity psychotic experiences on the Questionnaire for Psychotic Experiences; L, lifetime; C, current.
aReduced sample of 14 (see “Methods” section).
bInternal consistency is represented in bold on the diagonal and are reported as Cronbach’s α. Inter-subscale correlations ** significant at 
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A particular strength of this study was that all of the 
173 participants completed exactly the same assessment, 
including the extra measures used to determine validity. 
This ensured that we can be confident about our conver-
gent and discriminant validity correlations (Terwee et al22 
state that greater than n = 50 participants are required for 
such inter-scale correlations).
This study has several limitations. The cohort overall 
is a sizeable sample, however, modest for each diagnostic 
groups. Given that the analyses reported for the current 
study were always completed on the entire cohort, this 
reduces the impact of this limitation. In addition, our 
focus was on symptoms and not diagnostic groups, the 
symptom profile across the cohort being homogeneous. 
The sample size was small for our test–retest and inter-
rater reliability components. Ideally, we would have pre-
ferred to assess more participants, but funding and time 
restrictions limited these reliability assessments to 10% of 
the cohort. Finally, the current project was only able to 
recruit a psychiatric sample, as well as a nonclinical sam-
ple. This limits the generalizability of the psychometrics 
to alternate groups. Further work will need to confirm 
whether the QPE has the same favorable psychometrics 
properties in neurological samples and those with a med-
ical disorder.
In conclusion, the English version of the QPE is a psy-
chometrically sound measure of psychotic experiences. 
It offers a comprehensive phenomenological assessment, 
which includes hallucinations across several modali-
ties and delusions across multiple themes. It was easy to 
administer and well-accepted by participants. The QPE 
fulfils a need that the research and clinical communities 
have for a transdiagnostic assessment of psychotic expe-
riences. In addition, the QPE could be used as an out-
come measure for intervention research.
Supplementary Material
Supplementary data are available at Schizophrenia 
Bulletin online.
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